z-logo
open-access-imgOpen Access
Human thrombopoietin: gene structure, cDNA sequence, expression, and chromosomal localization.
Author(s) -
Donald C. Foster,
Cindy A. Sprecher,
Francis James Grant,
Janet Kramer,
Joseph L. Kuijper,
Richard D. Holly,
Theodore E. Whitmore,
Mark Heipel,
L. Anne Bell,
Andrew Ching
Publication year - 1994
Publication title -
proceedings of the national academy of sciences of the united states of america
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.91.26.13023
Subject(s) - thrombopoietin , biology , microbiology and biotechnology , complementary dna , locus (genetics) , cdna library , gene , southern blot , genetics , haematopoiesis , stem cell
Thrombopoietin (TPO), a lineage-specific cytokine affecting the proliferation and maturation of megakaryocytes from committed progenitor cells, is believed to be the major physiological regulator of circulating platelet levels. Recently we have isolated a cDNA encoding a ligand for the murine c-mpl protooncogene and shown it to be TPO. By employing a murine cDNA probe, we have isolated a gene encoding human TPO from a human genomic library. The TPO locus spans over 6 kb and has a structure similar to that of the erythropoietin gene (EPO). Southern blot analysis of human genomic DNA reveals a hybridization pattern consistent with a single gene locus. The locus was mapped by in situ hybridization of metaphase chromosome preparations to chromosome 3q26-27, a site where a number of chromosomal abnormalities associated with thrombocythemia in cases of acute myeloid leukemia have been mapped. A human TPO cDNA was isolated by PCR from kidney mRNA. The cDNA encodes a protein with 80% identity to previously described murine TPO and is capable of initiating a proliferative signal to murine interleukin 3-dependent BaF3 cells expressing the murine or human TPO receptor.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here